The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent AMR (NYSE: AMR) files for Chapter 11. (Reuters) S&P cuts its ratings on…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie…
The DJIA jumped above 12,000 in the opening minutes of trading this morning and had topped 12,200 by mid-afternoon. European Union leaders have agreed on a deal that would make up to…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit…
Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what about when a company decides to unlock shareholder value by breaking itself…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and…
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day at…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Applied Materials Inc. (NASDAQ: AMAT) Cut to Sell at Goldman…
A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type of arrhythmia…
LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung to delay its tablet launch in the U.S. because of IP lawsuits…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition. While this…
We may have just witnessed an oversold bounce in the stock market, or we may be in for more days of recovery. The markets are flirting with six weeks of negative performance…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Aixtron SE (NASDAQ: AIXG) Cut to Sell at Canaccord Genuity. Bristol-Myers Squibb Company…
